SYROS PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2022-09-21: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2022-09-16; Total offering amount $129,843,346.
- 2020-12-17: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2020-12-08; Total offering amount $121,609,375.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2022-09-21 | Rule 506(b) | Equity; OptionToAcquire | 2022-09-16 | $129,843,346 | $129,843,346 | $0 | 19 |
| 2020-12-17 | Rule 506(b) | Equity; OptionToAcquire | 2020-12-08 | $121,609,375 | $90,490,000 | $31,119,375 | 8 |